Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck will delay filing Ebola vaccine for approval until 2018, company confirms
Merck will delay filing Ebola vaccine for approval until 2018, company confirms
Merck will delay filing Ebola vaccine for approval until 2018, company confirms
Submitted by
admin
on November 25, 2017 - 12:30pm
Source:
Fierce Pharma
News Tags:
Merck
Ebola
vaccines
Headline:
Merck will delay filing Ebola vaccine for approval until 2018, company confirms
Do Not Allow Advertisers to Use My Personal information
